One randomized clinical trial detected a decrease in several systemic inflammatory markers like CRP and TNF-α in FM/CFS patients after an oral intake of Bifidobacterium infantis [138]. This evidence concerns the gene TNF and myalgic encephalomeyelitis/chronic fatigue syndrome.